InVivoMAb anti-mouse CD8alpha

Wang W, Marinis JM, Beal AM, et al. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Cancer Cell. 2018,34(5):757-774.e7. doi: 10.1016/j.ccell.2018.10.006

Finisguerra V, Di Conza G, Di Matteo M, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015,522(7556):349-53. doi: 10.1038/nature14407

Yamada DH, Elsaesser H, Lux A, et al. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. Immunity. 2015,42(2):379-390. doi: 10.1016/j.immuni.2015.01.005

Christensen AD, Skov S, Kvist PH, et al. Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells. Clin Exp Immunol. 2015,179(3):485-99. doi: 10.1111/cei.12466

Walsh KB, Teijaro JR, Brock LG, et al. Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. J Virol. 2014,88(11):6281-93. doi: 10.1128/JVI.00464-14

Uddin MN, Zhang Y, Harton JA, et al. TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma. J Immunol. 2014,192(4):1946-53. doi: 10.4049/jimmunol.1301976

Cyktor JC, Carruthers B, Beamer GL, et al. Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. PLoS One. 2013,8(3):e58612. doi: 10.1371/journal.pone.0058612

Schwager K, Hemmerle T, Aebischer D, et al. The immunocytokine L19-IL2 eradicates cancer when used in combination with CTLA-4 blockade or with L19-TNF. J Invest Dermatol. 2013,133(3):751-758. doi: 10.1038/jid.2012.376

Hervieu A, Rébé C, Végran F, et al. Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. J Invest Dermatol. 2013,133(2):499-508. doi: 10.1038/jid.2012.273

Hafalla JC, Claser C, Couper KN, et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology. PLoS Pathog. 2012,8(2):e1002504. doi: 10.1371/journal.ppat.1002504